Durham biotech secures $50M ahead of potential US contract for smallpox drug

The company's antiviral drug for smallpox was approved in 2021 and could end being added to the nation's Strategic National Stockpile.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 3, 2022 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news